501MCQforclinicalpharmacylast Ivrtjn
501MCQforclinicalpharmacylast Ivrtjn
501MCQforclinicalpharmacylast Ivrtjn
REVIEW IN CLINICAL
PHARMACY
For post-graduates
Editor
Hassan AL-Temimi
PhD Clinical Pharmacy
Reviewers
1. Dr Alaa A. Abdulrassoul – Prof. of pharmacy
2. Dr. Jaleel AL-Shemarry - Chest physician
3.Dr Jawad I. Rasheed - Consultant nephrologist
بسم هللا الرحمن الرحيم
ْ َ ُ ُ ْ َ َ َ َّ ُ َ ْ َ َ َّ َ َ ً َ ُ ُ َ َ َ َّ َّ َ ُ َ َ ْ
ض{
}فأمأ الزبد فيذهب جفأء وامأ مأ ينفع النأس فيمكث ِفي األر ِ
]الرعد[71 :
الفاتحة
على روح والدي وامواتنا وشهداء العراق
"نسالكم الدعاء"
This book is one of the series
edited by Hassan AL-Temimi and
reviewed by academic advisor in
the field of internal medicine and
clinical pharmacy. The main aim of
this series is to provide a guide in
clinical pharmacy for internal
medical students and clinical
pharmacy students. the series (
001) is a part of clinical pharmacy
board review.
EDITOR
Dr. Hassan Mohammed Abbas AL-Temimi
PhD Clinical Pharmacy
Director of Training Center of Clinical
Pharmacy Board
Medical city - Baghdad
501 MCQs \ REVIEW IN CLINICAL PHARMACY Dr. Hassan AL-Temimi 1
NOTICE
Editor
2014
501 MCQs \ REVIEW IN CLINICAL PHARMACY Dr. Hassan AL-Temimi 2
2-The most effective strategy to reduce the occurrence of neural tube defects in
infants is:
A-Pyridoxine
B-Doxylamine
C-Prednisone
D-Metoclopramide
E-Prochlorperazine
A-Bed rest
B-Oral methyldopa
C-Oral calcium supplementation
D-Oral lisinopril
E-Intravenous magnesium sulfate infusion
6-Which of the following adverse effects can occur with hydroxychloroquine but
not with other commonly used agents in SLE?
8-An appropriate preventive treatment regimen for a pregnant woman who has
four migraine headaches per month is:
A-Sumatriptan
B-Ergotamine
C-Caffeine
D-Ibuprofen
E-Propranolol
9-The most appropriate treatment regimen for a pregnant woman with persistent
asthma previously maintained on fluticasone, salmeterol, and albuterol is:
11-Which of the following agents is the most effective for cervical ripening and
labor induction?
A-Oral misoprostol
501 MCQs \ REVIEW IN CLINICAL PHARMACY Dr. Hassan AL-Temimi 4
B-Intravaginal misoprostol
C-DinoprostoneD-Oxytocin
E-Mifepristone
12-First-line therapy for a woman diagnosed with gestational diabetes mellitus is:
A-Recombinant insulin
B-Exercise
C-Glyburide
D-Metformin
E-Diet modification
A-Lipophilicity
B-Low molecular weight
C-High protein binding
D-Maternal serum concentration
E-Weakly basic pH
16-A woman who is 6 weeks postpartum and breastfeeding seeks contraception. She
would like to have another child in 1 year. Which of the following is the preferred
method of contraception?
A-Combined oral contraceptive
B-Progestin-only oral contraceptive
C-Depo-medroxyprogesterone acetate
D-Transdermal contraceptive
501 MCQs \ REVIEW IN CLINICAL PHARMACY Dr. Hassan AL-Temimi 5
17-A 32-year-old obese woman comes to the pharmacy to pick up her prescription for
norgestimate/ethinyl estradiol (Ortho-Cyclen). A pack of cigarettes falls out of her
purse. This is a concern because:
18-A 21-year-old woman comes to the pharmacy for her second refill of
norethindrone/ethinyl estradiol (Ortho-Novum 7/7/7). She is complaining of nausea
and breast tenderness and wonders if you can recommend something for this problem.
You recommend that she:
A-Call her physician to change her prescription to another oral contraceptive with less
estrogen
B-Buy a home pregnancy test to rule out pregnancy
C-Wait another 1 to 2 months to see if symptoms improve on her condition
D-Take a multivitamin rich in B vitamins to treat her symptoms
19- An 18-year-old woman with a seizure disorder and active STD seeks contraception
today. She is taking carbamazepine and azithromycin. Which of the following
contraceptive methods would be most appropriate?
A-Combined oral contraceptive (with 35 mcg of ethinyl estradiol)
B-Depo-medroxyprogesterone acetate
C-Transdermal contraceptive
D-Levonorgestrel intrauterine device
20- A 23-year-old frantic woman comes to the pharmacy asking for help in choosing a
home pregnancy test. She says that her partner’s condom broke during intercourse last
night and that she’s worried that she might be pregnant. She started her last period 18
days ago. You recommend that she:
21- A 22-year-old woman has been using Depo-Provera for the past year. She comes
to the office for her quarterly injection (her last injection was 13 weeks ago). The
nurse asks you about the administration of Depo-Provera, and you recommend
that she:
A-Have the patient wait until her next menses before receiving the injection
B-Return to the office next week for her injection
501 MCQs \ REVIEW IN CLINICAL PHARMACY Dr. Hassan AL-Temimi 6
C-Give the injection today but use a second method of contraception for the next cycle
D-Do a pregnancy test and if negative give the injection today
23- Oral contraceptives are associated with a known decreased risk for which of
the following conditions?
A-Breast cancer
B-Pelvic inflammatory disease
C-Hepatic adenomas
D-Cerebrovascular disease
A-Take an active tablet as soon as possible (two tablets on that day) and then continue
taking tablets daily, one each day. No additional contraceptive protection is
recommended.
B-Take an active tablet as soon as possible (two tablets on that day) and then continue
taking tablets daily, one each day. Use condoms or abstain from sex until tablets have
been taken for 7 days in a row. Finish the active tablets in the current pack and start a
new pack the next day (i.e., do not take the seven inactive tablets).
C-Discard the current pack, allow bleeding to occur and then restart a new pack, taking
one tablet each day. Use condoms or abstain from sex until the new pill pack has been
taken for 7 days in a row.
D-Take an active tablet as soon as possible (two tablets on that day) and then continue
taking tablets daily, one each day. Use condoms or abstain from sex until tablets have
been taken for 7 days in a row.
A-Inhibition of implantation
B-Accelerated ovum transport
C-Inhibition of ovulation
D-Production of thick cervical mucous
30-A 25-year-old, 103-kg (227 lbs) woman requests hormonal contraception. Which
method would be inappropriate and should not be considered?
33-R.D. is a 40-year-old female who has not had a period for 7 months. She is not
pregnant, and her TSH and prolactin concentrations are within normal ranges. She
displays no symptoms of PCOS. Which of the following is most appropriate for RD
at this time?
A-A combination oral contraceptive with 50 mcg ethinyl estradiol plus desogestrel
B-Mefenamic acid 500 mg by mouth followed by 250 mg by mouth 4 times daily
during menses
C-Levonorgestrel IUD releasing 20 mcg levonorgestrel daily
D-Medroxyprogesterone acetate 10 mg by mouth on days 5 to 26 of the menstrual
cycle
C-It is a therapeutic option for any woman at low risk for sexually transmitted diseases
D-Its use increases the need for hysterectomy.
A-Hyperprolactinemia
B-Hyperthyroidism
C-PC
D-Primary pituitary disease
37-B.B. is a 32-year-old female who presents with complaints of irregular menses. She
is hirsute around the jaw line, her BMI is 32 kg/m2, and her waist circumference is 40
inches (102.6 cm). A pelvic ultrasound reveals polycystic ovaries. Which of the
following is most appropriate for B.B.?
A-Hypoprothrombinemia
B-Hyperandrogenism
C-Hypoestrogenism
D-Hypothyroidism
501 MCQs \ REVIEW IN CLINICAL PHARMACY Dr. Hassan AL-Temimi 10
A-20
B-40
C-70
D-90
45-For a woman diagnosed with PMDD, following two cycles of charting her
symptoms and attempting (and failing) non-pharmacologic interventions, a SSRI is
initiated. Which of the following is a clinical controversy surrounding the use of
this drug class in PMDD?
given patient characteristics, which of the following is the best choice of therapy
for RT’s painful symptoms?
A-Naproxen
B-Leuprolide
C-Oral contraceptive
D-Medroxyprogesterone depot injection
A-Ibuprofen
B-Danazol
C-Conservative surgery
D-Nonconservative surgery
50-A 40-year-old woman with endometriosis is being treated with goserelin, and her
physician wishes to start add-back therapy to relieve her hot flashes and prevent bone
loss. The purpose of using add-back therapy includes which of the following?
I: Improved efficacy
501 MCQs \ REVIEW IN CLINICAL PHARMACY Dr. Hassan AL-Temimi 12
51-KH is a 13-year-old female patient with endometriosis. Her pain failed to respond
to therapy with ibuprofen. Which of the following agents is the best to recommend
for KH at this time?
A-Danazol
B-Levonorgestrel intrauterine system
C-Nafarelin
D-Ethinyl estradiol/norgestimate contraceptive pill
A-Danazol
B-Medroxyprogesterone acetate.
C-Nafarelin
D-Naproxen
53-TS is a 30-year-old woman who recently started danazol for the treatment of
endometriosis-related pain. Which of the following is an appropriate monitoring
plan for this patient?
A-Pain relief at 2 months; incidence of hot flashes, vaginal dryness, and insomnia
B-Pain relief at 2 months; incidence of weight gain, acne, and hirsutism
C-Pain relief at 6 months; incidence of hot flashes, vaginal dryness, and insomnia
D-Pain relief at 6 months; incidence of weight gain, acne, and hirsutism
A-Prostaglandin release
B-Bleeding
C-Compression of nerve fibers
D-Increased levels of substance P
60-Which of the following patients would be the best candidate for use of an
aromatase inhibitor in treating endometriosis pain?
A-Estrogen therapy
B-Selective estrogen-receptor modulators (SERMs)
C-Testosterone therapy
D-Clonidine
62-In order to prevent future coronary events in a 65-year-old woman who recently
underwent coronary artery bypass grafting, the following hormone therapy regimen
should be initiated:
A-Venous thromboembolism
B-Stroke
501 MCQs \ REVIEW IN CLINICAL PHARMACY Dr. Hassan AL-Temimi 15
C-Colon cancer
D-Both a and b
E-Both a and c
66-For the management of severe menopausal symptoms, the best choice for a 55-
year-old woman with breast cancer is:
A-Estrogen
B-Progestogen
C-Venlafaxine
D-Tibolone
A-FSH
B-LH
C-estradiol
D-TSH
A-Breast cancer
B-Thromboembolic disease events
C-Coronary heart disease events
D-Both choices a and c
E-Both choices b and c
A-Venous thromboembolism
B-Breast cancer
C-Colon cancer
D-Inflammatory bowel disease
E-None of the above choices is correct
501 MCQs \ REVIEW IN CLINICAL PHARMACY Dr. Hassan AL-Temimi 16
A-Estrogen
B-Raloxifene
C-Clonidine
D-Testosterone
A-Gastrointestinal upset
B-Hot flushes
C-Vaginal spotting
D-Headache
A-The three main classes of phytoestrogens are isoflavones, lignans, and coumesta
B-Hepatotoxicity has been reported with black cohosh administration.
C-Red clover leaf contains phytoestrogens.
D-Herbal products marketed for the relief of menopausal symptoms have been shown
to be effective and therefore should be recommended.
76-All of the following are potential risks for plasma-derived factor concentrates,
except:
501 MCQs \ REVIEW IN CLINICAL PHARMACY Dr. Hassan AL-Temimi 17
A-HIV contamination
B-Hepatitis contamination
C-Development of factor inhibitor
D-Renal toxicity
E-Allergic reaction
A-2,000 units
B-1,750 units
C-1,250 units
D-1,000 units
E-625 units
79-Which of the following is not an appropriate choice for the acute treatment of
a patient with hemophilia A who is bleeding and has a high titer inhibitor?
A-Cyclophosphamide
B-Factor VIIa concentrate
C-PCCs
D-Porcine factor VIII
E-aPCCs
A-Facial flushing
B-Water retention
C-Headache
D-Seizures
E-All of the above
81-Which of the following is least likely to occur in a patient with type 1 von
Willebrand disease?
B-Menorrhagia
C-Postoperative bleeding
D-Nosebleed
E-Joint hemorrhage
82-A patient with type 2N von Willebrand disease is receiving a plasma derived
von Willebrand factor containing product. You can monitor all of the following,
for efficacy except:
83-Which of the following is the least likely to occur in a patient with mild factor
VIII deficiency?
A-Fibrinogen
B-D-dimer
C-Bleeding time
D-A and B
E-A and C
85-A patient presents with septic shock and disseminated intravascular coagulation
from bacterial sepsis. Which of the following agents is most likely to have the
greatest impact on the patient’s outcome?
A-Activated protein C
B-Antithrombin
C-Heparin
D-Antibiotics
E-Fresh frozen plasma
B-Acute diarrhea
C-Cystic fibrosis
D-A and B
E-A and C
A-Subcutaneous phytonadione
B-Intramuscular phytonadione
C-Oral phytonadione
D-Intramuscular menadion
E-Oral menadiol
88-All of the following are possible methods of viral inactivation for plasma
derived factor replacement products except:
A-Recombinant technology
B-Solvent detergent
C-Dry heat
D-Pasteurization
E-Monoclonal antibody
A-Bleeding time
B-Thrombin time
C-Activated partial thromboplastin time (aPTT)
D-Prothrombin time (PT)
E-Platelet count
92-Patients with sickle cell anemia have increased risk of the following infection:
A-Streptococcus pneumonia
B-Candida species
C-Aspergillus species
D-Pseudomonas species
E-Enterobacter species
A-Hydroxyurea is useful in the management of sickle cell disease because the agent is
efficacious in reducing pain crisis and has no toxicities.
B-Hydroxyurea is preferred over butyrate because of its sustained effect on fetal
hemoglobin and lack of side effects with long-term use.
C-Hydroxyurea reduces painful crisis but close monitoring is needed because of its
effect on the bone marrow.
D-Chronic transfusion is the therapy of choice to increase fetal hemoglobin.
E-Penicillin prophylaxis can be discontinued once fetal hemoglobin inducer is
initiated.
A-Prevention of infection
B-Prevention of organ damage
C-Lack of fetal hemoglobin response to hydroxyurea
D-Bone marrow suppression secondary to hydroxyurea
E-Prevention of stroke
99-Patients admitted with signs and symptoms of acute chest syndrome should
A-Pneumococcal infection
B-ASPEM syndrome occurred after partial exchange transfusion in patients with
priapism
C-Parvovirus B19
D-Sequestration of red blood cells in the spleen
E-Splenectomy
501 MCQs \ REVIEW IN CLINICAL PHARMACY Dr. Hassan AL-Temimi 22
A-Hydration and aggressive analgesics are the primary treatment. Analgesic therapy
should be individualized.
B-Narcotic analgesics should be minimally used because patients can become addicted
to those agents.
C-Patients who require narcotic analgesics more than 24 hours are drug-seeking.
D-All patients with pain crisis should be hospitalized.
E-Fluid restriction should be initiated to prevent fluid overload.
102-Analgesic choices for sickle cell patients with mild to moderate pain include
the following except:
103-Analgesic choices for sickle cell patients with severe pain include the
followings except:
A-Morphine
B-Hydromorphone
C-Fentanyl
D-Acetaminophen
E-Methadone
A-It limits the allowable amount that can be delivered to the patient; therefore,
avoiding confrontations with the patient.
B-This method of delivery resulted in increased duration of action.
C-Intramuscular administration of narcotic agents should be avoided, especially for
young children.
D-It gives the patient control over the analgesic therapy.
E-It minimize addition potential.
A-aplastic anemia
B-thrombocytopenia
C-agranulocytosis
501 MCQs \ REVIEW IN CLINICAL PHARMACY Dr. Hassan AL-Temimi 23
D-hemolytic anemia
E-megaloblastic anemia
A-dose-dependent
B-idiosyncratic
C-metabolite-induced immune reaction
D-a and b
E-a and c
107-The major cause of mortality among patients with aplastic anemia is:
A-bleeding
B-thrombosis
C-embolism
D-infection
E-hypoxia
A-Weight loss
B-Anemia
C-Sore throat
D-Dysphagia
110-The cornerstone in the evaluation of the patient with digestive complaints is:
111-Bleeding from the GI tract may lead to elevations in which of the following
laboratory tests?
A-Prealbumin
B-Serum creatinine
C-Serum potassium
D-Blood urea nitrogen
A-Hepatic dysfunction
B-Malnutrition
C-Protein losing-enteropathies
D-All of the above
A-Helicobacter pylori
B-Escherichia coli
C-Cytomegalovirus
D-Clostridium difficile
A-Radionuclide imaging
B-Computed tomography
C-Magnetic resonance imaging
D-None of the above
117-To improve patient acceptance with upper endoscopy, which of the following
agents can be used to achieve conscious sedation?
A-Lorazepam
B-Midazolam
C-Propofol
D-All of the above may be used
B-Endoscopy
C-Magnetic resonance imaging
D-All of the above may be used
A-10 %
B-25%
C-50%
D-75%
A-Capsule endoscopy
B-Enteroscopy
C-Manometry
D-Upper GI series
A-Capsule endoscopy
B-Flexible sigmoidoscopy
C-Magnetic resonance imaging
D-Esophageal pH monitoring
123-Aggressive factors that can promote esophageal damage include all of the
following except:
A-Bicarbonate
B-Gastric acid
C-Pancreatic enzymes
D-Bile acids
E-Pepsin
A-Dose-dense CHOP
B-Escalated-dose BEACOPP
C-BEACOPP-14
D-All of the above
A-Dysphagia
B-Fatigue
C-Painless lymphadenopathy
D-All of the above
128-Which of the following tests is routinely done in the diagnosis of patients with
MDS?
A-Bevacizumab
B-Pazopanib
C-Sorafenib
D-Sunitin
501 MCQs \ REVIEW IN CLINICAL PHARMACY Dr. Hassan AL-Temimi 27
E-Temsirolimus
A-Doxorubicin
B-Cyclophosphamide
C-Paclitaxel
D-Tamoxifen
131-MB is a 74-year-old male with MDS. His hemoglobin is 6.8 g/dL, neutrophil
count is 0.8 * 109cells/L, and platelets are 43 ? 109 cells/L. Bone marrow biopsy
reveals 9% blasts. His cytogenetics are normal. What is his IPSS score?
A-0
B-1
C-1.5
D-2
134-What is the most effective therapy for a 37-year-old female with refractory
anemia with excess blasts-2 (RAEB-2) noted to have a chromosome 7
abnormality?
C-Lenalidomide
D-Darbepoetin
A-Azacitidine
B-Lenalidomide
C-AML-type induction chemotherapy
D-Romiplostim
137-Mr. Smith is a 78-year-old male with a past medical history of heart failure, type
II diabetes, and myelodysplastic syndrome-refractory anemia with excess blasts-2
(RAEB-2). He read about iron overload on the MDS foundation website and would
like to know what benefits he would have from receiving deferasirox. You explain to
him that treatment of MDS with deferasirox has been shown to do which of the
following?
A-A 27-year-old female requiring 6 red blood cell transfusions/month for the past 3
months with a serum erythropoietin level of 672 MIU/mL
B-A 63-year-old male requiring 3 red blood cell transfusions/month for the past 2
years with a serum erythropoietin level of 512 MIU/mL
C-A 72-year-old female requiring 1 red blood cell transfusion/month for the past 3
months with a serum erythropoietin level of 172 MIU/mL
D-A 63-year-old male requiring 1 red blood cells transfusions/month for the past 2
years with a serum erythropoietin level of 430 MIU/mL
501 MCQs \ REVIEW IN CLINICAL PHARMACY Dr. Hassan AL-Temimi 29
A-Oncogene
B-Tumor suppressor gene
C-Receptor tyrosine kinase endothelial growth factor (VEGF)
D-Substrate for vascular
501 MCQs \ REVIEW IN CLINICAL PHARMACY Dr. Hassan AL-Temimi 30
145-The current treatment of RCC has shifted towards targeted therapy against a
variety of substances that play a role in the pathogenesis of the disease. All of the
following are genes that are directly activated by the HIF complex except:
A-Glucose transporter-1
B-Vascular endothelial growth factor (VEGF)
C-Mammalian target of rapamycin (mTOR)
D-Platelet-dependent growth factor (PDGF)
A-Bevacizumab
B-Interleukin-2
C-Interferon
D-Pazopanib
E-Everolimus
A-Sorafenib
B-Sunitinib
C-Interferon
D-Interluekin-2
E-Temsirolimus
148-Which of the following targeted therapies is the best choice for the first-line
treatment of metastatic RCC in a patient with an MSKCC risk classification of
poor risk (three or four of five factors)?
A-Sunitinib
B-Temsirolimus
C-Sorafenib
D-Bevacizumab
E-Everolimus
149-Which of the following targeted therapies is the best choice for the second-
line treatment of metastatic RCC in an individual who has experienced disease
progression on a tyrosine kinase inhibitor?
A-Temsirolimus
B-Bevacizumab
C-Sorafenib
D-Pazopani
E-Everolimus
501 MCQs \ REVIEW IN CLINICAL PHARMACY Dr. Hassan AL-Temimi 31
A- 4 mg daily
B- 5 mg daily
C- 7 mg daily
D- 10 mg daily
E- 15 mg daily
152-A 55-year-old male with type 2 diabetes is seen at annual review. His glycaemic
control is sub-optimal on diet alone and his most recent HbA1c is 7.9% (3.8-6.4). You
elect to treat him with metformin 500 mg BD. Which of the following would be the
most appropriate interval to re-check his HbA1c?
A- Two weeks
B- One month
C- Two - three months
D- Four - six months
E- Six - twelve months
153-What is the most effective bisphosphonate for use in reducing bone pain and
preventing pathological fractures in patients with metastatic breast cancer?
A- Alendronic acid
B- Ibandronic acid
C- Olpadronate
D- Pamidronate
E- Zoledronic acid
154-A 72-year-old man presents to the hematology clinic. He has suffered increasing
headaches over the past few weeks, and unfortunately suffered a myocardial infarction
some four weeks ago. He has been buying anti-histamines over the counter because of
increasing itching. During his admission it was noted that he had a marked elevation in
hemoglobin, white cells and platelets. He is a non-smoker with no history of chest
disease. On examination in the clinic today he is hypertensive with a BP of 155/90
501 MCQs \ REVIEW IN CLINICAL PHARMACY Dr. Hassan AL-Temimi 32
mmHg. Heart sounds are normal and his chest is clear. He looks plethoric with a ruddy
complexion, and you notice that he has splenomegaly on abdominal examination.
Investigations show
Hemoglobin 19.8 g/dl(13.5-18)
Staining for estrogen and progesterone receptors is negative.
Which of the following additional treatment options is most appropriate, based
upon these findings?
A- Radical mastectomy
B- St John's wort
C- Tamoxifen
D- Trastuzumab
E- Vancomycin
155-A 28-year-old pregnant woman is being treated for a deep vein thrombosis with
unfractionated heparin. A recent blood test shows:
Hemoglobin 9.8 g/dl(11.5-16.5)
White cell count 9.5 x 109/L (4-11)
Platelets 35 x 109/L (150-400)
What would be the best course of action for this woman?
A- Change to hirudin
B- Change to low molecular weight heparin
C- Change to warfarin
D- Danaparoid
E- No change in treatment and observe
157-A 68-year-old female with terminal bowel cancer is receiving optimal doses of
morphine sulphate therapy. Which of the following effects may be expected with the
addition of a partial opioid agonist?
A- Increased analgesia
B- Increased respiratory depression
C- Increased sedation
D- No change
E- Reduced analgesia
501 MCQs \ REVIEW IN CLINICAL PHARMACY Dr. Hassan AL-Temimi 33
158-Which of the following does not have a role in the management of chronic
cancer pain?
A- Carbamazepine
B- Clodronate
C- Dexamethasone
D- Nifedipine
E- Pinavarium
159-A previously fit 30-year-old male presents with a two month history of weight
loss, tiredness and nausea.
Investigations show:
Haemoglobin 10.5 g/dL (13.0-18.0)
MCV 88 fL (80-96)
White cell count 6.0 x 109/L (4-11 x109)
Platelets 450 x 109/L (150-400 x109)
Serum Sodium 130 mmol/L (137-144)
Serum Potassium 5.7 mmol/L (3.5-4.9)
Serum Urea 3.0 mmol/L (2.5-7.5)
Serum creatinine 78 μmol/L (60-110)
Serum total T4 55 nmol/L (50-150)
Serum TSH 8 mU/L (0.4-5)
Which of the following is the most useful diagnostic investigation?
160-By what mechanism do the platinum based chemotherapies cause DNA damage
and cell death?
A- Alkylating agent
B- Antimetabolite
C- DNA cross linkage
D- Inhibition of topoisomerase
E- Unknown
161-A 35-year-old woman is diagnosed with a below knee deep vein thrombosis
(DVT). She is currently undergoing endocrine treatment for breast cancer. Which
agent is she likely to have been prescribed?
A- Anastrozole
B- Exemestane
C- Fulvestrant
D- Megace
501 MCQs \ REVIEW IN CLINICAL PHARMACY Dr. Hassan AL-Temimi 34
E- Tamoxifen
163-A 48-year-old woman with a history of epilepsy and ischemic heart disease
presented with the following full blood count.
Hemoglobin 7.4 g/dL(11.5 - 16.5)
Mean cell volume 125 fL(80 - 96)
White cell count 2.5 x 109/L(4 - 11)
Platelet count 130 x 109/L(150 - 400)
Which of the following medications is the most likely cause?
A- Carbamazepine
B- Clopidogrel
C- Furosemide
D- Phenytoin
E- Spironolactone
A- Aspirin
B- Intravenous unfractionated heparin
C- Warfarin
D- Subcutaneous low molecular weight heparin
E- Subcutaneous unfractionated heparin
A- Activation of plasminogen
B- Chelation of calcium
C- Inhibition of activated factor X
D- Inhibition of antithrombin
E- Inhibition of vitamin K-dependent carboxylase
166-A 73-year-old man presented with a two weeks history of breathlessness and easy
bruising. Investigations show:
501 MCQs \ REVIEW IN CLINICAL PHARMACY Dr. Hassan AL-Temimi 35
A- Aciclovir
B- Amiloride
C- Amoxicillin
D- Paracetamol
E- Trimethoprim
A- Mefenamic acid
B- Tranexamic acid
C- Vasopressin
D- Vitamin K
E- von Willebrand factor
168-A 35-year-old male with a long history of ulcerative colitis is treated for an acute
exacerbation which settles following an alteration of his medication. Six weeks after
discharge he is re-admitted with sepsis and his results show:
Haemoglobin 10.5 g/dl(13.0-18.0)
White cell count 2.0 x 109/L (4-11)
Platelets 90 x 109/L (150-400)
Which one of the following drugs is most likely to be the cause of his
pancytopenia?
A- Azathioprin
B-Mesalazine
C-Metronidazole
D-Pamidronate
E- Prednisolone
A- Ibuprofen
B- Loperamide
C- Mefloquine
D- Primaquine
E- Yellow fever vaccine
501 MCQs \ REVIEW IN CLINICAL PHARMACY Dr. Hassan AL-Temimi 36
A- Aspirin
B- Menstruation
C- Phenytoin
D- Starvation
E- Thiopentone
A- Bioavailability
B- First pass metabolism
C- Gastric emptying
D- Plasma half life
E- Renal clearance
172-Which of the following statements is true about the storage conditions and
shelf life of blood products?
A- Fresh frozen plasma is stored at -30c for up to 24 months
B- Fresh frozen plasma is stored at -30c for 12 months
C- Packed red cells are stored at 4c for up to 25 days
D- Platelets are stored at 22c for up to 10 days
E- Platelets are stored at 4c for up to five days
173-A 70-year-old woman is on multiple medications for various conditions and she is
found to have a macrocytic anemia with a low serum B12.
Which of the following medications is a possible cause of the B12 deficiency?
A- Amiodarone
B- Ezetimibe
C- Metformin
D- Nicotinic acid
E- Sodium valproate
174-A 20-year-old man presented to hospital two days after returning from visiting his
family in Bangladesh. Within a day of his return to the United Kingdom he suddenly
developed profuse watery diarrhea. He says there had been an outbreak of diarrhea in
his family's village in the week before his return. Stool culture revealed a growth of
Vibrio cholera. Which one of the following blood types is associated with the
greatest susceptibility to severe cholera?
A- Blood Group A
B- Blood Group AB
C- Blood Group B
D- Blood Group O
501 MCQs \ REVIEW IN CLINICAL PHARMACY Dr. Hassan AL-Temimi 37
E- Rhesus –ve
A- Aspirin
B- B- Intravenous unfractionated Heparin
C- Subcutaneous low molecular weight Heparin
D-Subcutaneous unfractionated Heparin
E-Warfarin
A- Metronidazole.
B- Cephazolin
C- Amoxicillin
D-Tetracycline
E- Clindamycin
177-A young teenager presents with fever and headache. He has received oral
Amoxicillin for 3 days. Which of the following CSF findings would exclude a
partially treated meningitis?
179-An 18-year-old male presented with a two-week history of dysuria and purulent
penile discharge. Gram stain of a urethral swab showed Gram-negative intracellular
diplococci. What specific treatment should he receive?
A- Cefixime
501 MCQs \ REVIEW IN CLINICAL PHARMACY Dr. Hassan AL-Temimi 38
B- Cephradine
C- Ciprofloxacin
D- Co-amoxiclav
E- Crystalline penicillin
180-A 35-year-old man presented with cellulitis of his right leg. On examination he
was mildly confused and febrile (40.1?) with a pulse was 120 / minute and BP 80/55
mmHg. He was treated with intravenous benzylpenicillin and flucloxacillin. Group A
Streptococcus was isolated from two sets of blood cultures. There was no significant
clinical improvement after 24 hours. What antibiotic should be added?
A- Ciprofloxacin
B- Clindamycin
C- Gentamicin
D- Rifampicin
E- Vancomycin
182-A 57-year-old woman develops a blistering rash around the mid riff and is
diagnosed with herpes zoster. She is treated with acyclovir. Through inhibition of
which of the following does acyclovir function?
A- Integrase
B- Polymerase
C- Protease
D- Reverse transcriptase
E- Thymidine kinase
183-A 62-year-old lady is due to attend her dentist for a hygiene appointment for
scaling. She has a history of mitral valve prolapse with regurgitation and is allergic to
penicillin. Which of the following antibiotics would be the most appropriate
choice for prophylaxis in this lady?
A- Oral clindamycin
B- Oral doxycycline
C- Oral erythromycin
D- Oral ofloxacin
E- No antibiotic prophylaxis
501 MCQs \ REVIEW IN CLINICAL PHARMACY Dr. Hassan AL-Temimi 39
184-A 17-year-old girl presents with 3 day history of vaginal discharge. What is the
most likely causative organism?
A- Candida albicans
B- Bacterial vaginosis
C- Chlamydia trachomatis
D- Neisseria gonorrhoea
E- Trichomonas vaginalis
185-A 15-year-old female is a close contact of a student who has developed meningitis
C. The last contact she had with her friend was two days ago when her friend
developed headache. She has not received any previous vaccination for meningitis.
What is the most appropriate action for this girl?
186-A 28-year-old man had been treated for pulmonary tuberculosis with rifampicin,
isoniazid, pyrazinamide and ethambutol for four weeks. Pre-treatment liver function
tests were normal but his most recent investigations revealed:
serum total bilirubin 98 micromol/l (0-18)
serum alanine aminotransferase 620u/l (5-45)
serum aspartate aminotransferase 450 u/l (5-45)
serum alkaline phosphatase 720 u/l (40-110)
Which one of the following is the most appropriate next step?
187-A 23-year-old female presents 16 weeks into her pregnancy with a vaginal
discharge. Further investigation confirms infection with Chlamydia trachomatis.
Which of the following is the most appropriate treatment for this patient?
A- Azithromycin
B- Ciprofloxacin
C- Co-trimoxazole
D- Doxycycline
E- Metronidazole
501 MCQs \ REVIEW IN CLINICAL PHARMACY Dr. Hassan AL-Temimi 40
188-A 16-year-old boy presented with fever, headache and neck stiffness for 24 hours.
He had an identical illness requiring admission to hospital for 1 year previously.
Cerebrospinal fluid analysis shows White cells of 400/ml with a 90% neutrophilia and
gram stain revealed scanty gram-negative diplococci. Which component of the
immune system is likely to be defective?
A- B lymphocytes
B- Complement pathway
C- Immunoglobulin
D- Neutrophils
E- T lymphocytes
189-A 82-year-old lady is admitted from her nursing home with headache,
photophobia and neck stiffness. Her temperature is 39.0 C, pulse rate 115 beats/min.
There is no skin rash or focal neurological signs and her Glasgow coma scale is 15/15.
A CT scan shows no contraindication to lumbar puncture. CSF is obtained and Gram
stain shows Gram negative cocc-bacilli, subsequent culture confirms a Haemophilus
influenza meningitis. What chemoprophylaxis should be offered to the nurses at
her home?
A- Azithromycin
B- Ceftriaxone
C- Ciprofloxacin
D- no chemoprophylaxis required
E- Rifampicin
190-A 45-year-old man presented with a three day history of headache and increasing
confusion. On examination he was febrile with marked neck stiffness. Investigations
revealed:
Cerebrospinal fluid analysis (normal ranges are shown in brackets):
White cell count 600 /ml (< 5)
White cell differential > 90% neutrophils
Gram stain Gram-negative diplococci
Which one of the following antibiotics, given intravenously, is the most
appropriate treatment?
A- Ampicillin
B- Benzylpenicillin
C- Cefuroxime
D- Ciprofloxacin
E- Gentamicin
A- Cytomegalovirus
501 MCQs \ REVIEW IN CLINICAL PHARMACY Dr. Hassan AL-Temimi 41
B- Mumps
C- Rubella
D- Toxoplasma gondii
D- Varicella zoster virus
192-A 27-year-old female presents with persistent fatigue, myalgia, poor concentration
and irritability following a flu like illness 18 months previously. A diagnosis of
chronic fatigue syndrome is made. What is the appropriate initial management of
this patient?
A- Antidepressants
B- Cognitive behavioral therapy
C- ECT
D- Reversion therapy
E- Psychoanalysis
193-A 18-year-old male presents with a 6 week history of a painful swollen right knee.
He had been treated for a sexually transmitted disease 3 months ago. On examination
there was a large effusion in the right knee. Synovial fluid analysis revealed a white
cell count of 16 x 109/L but culture was negative. Which one of the following
organisms is the most likely cause?
A- Chlamydia trachomatis
B- Herpes simplex
C- Neisseria gonorrhoea
D- Treponema pallidum
E- Trichomonas vaginalis
A- Ciprofloxacin
B- Co-amoxiclav
C- Doxycycline
D- Metronidazole
E- Penicillin
195- A 17-year-old male from India presents with fever of 4 months duration and
splenomegaly. What is the most likely diagnosis?
A- Coccidiomycosis
B- Giardiasis
C- Tropical sprue
D- Typhoid
E- Visceral leishmaniasis
501 MCQs \ REVIEW IN CLINICAL PHARMACY Dr. Hassan AL-Temimi 42
A- Cefotaxime
B- Clarithromycin
C- Co-Amoxiclav
D- Minocycline
E- Vancomycin
197-A 72-year-old gentleman presents with increasing shortness of breath, fever and
cough. A chest X-ray shows findings consistent with a right middle lobe pneumonia.
Which factor is associated with a worse prognosis?
198-A 15 year-old girl presented with a 12-hour history of fever and global headache.
On examination she was febrile (37.5oC-. She was fully conscious. Mild neck stiffness
was noted but there were no other neurological signs. Cerebrospinal fluid analysis
showed:
Cell count 200 /mL (60% lymphocytes)
Protein 0.8 g/L
Glucose 4.3 mmol/L
Gram stain No organisms seen
What is the most likely diagnosis?
A- Bacterial meningitis
B- Cryptococcal meningitis
C- Lymphomatous meningitis
D- Tuberculous meningitis
E- Viral meningitis
A- Bordetella pertussis
B- Cryptococcus neoformans
C- Mycoplasma pneumoniae
D- Legionella pneumophila
E- Streptococcus Pneumonaie
501 MCQs \ REVIEW IN CLINICAL PHARMACY Dr. Hassan AL-Temimi 43
200-A 17-year-old man presented with a widespread maculopapular rash. He had been
prescribed Amoxicillin for exudative tonsillitis. What is the most likely diagnosis?
202-If one screening plasma glucose was diagnostic for diabetes mellitus, the
diagnosis of diabetes mellitus could be confirmed if the second laboratory reading
was a:
C-GLP-1, but not GIP reduces postprandial insulin resistance, improving insulin
secretion
D-GLP-1, but not GIP enhances satiety, lowers postprandial glucagon, and enhances
satiety
E-GIP and GLP-1 have identical mechanisms of action
206-Over the past 6 years, the dose of exenatide has been 10 mcg twice daily. H.A.
had an HbA1cof 7.2% 6 months ago, and pioglitazone 30 mg was added to the
regimen. The clinician should be aware that with the addition of pioglitazone:
207-A.J. is a 37-year-old female who has had type 1 DM since she was 9 years old.
She states that she currently has neuropathic gastroparesis and mild nonproliferative
background retinopathy. She controls the blood glucose by the following insulin
regimen: insulin glargine 20 units at bedtime and insulin lispro 1 unit for every 15
grams of carbohydrate at breakfast (~8 AM), lunch (~1 PM), dinner (~6 PM). In her
average glucose readings over last 2 weeks prior to meals and at bedtime, no low
glucose readings are noted:
morning, 182 mg/dL;
noon, 125 mg/dL;
afternoon, 120 mg/dL;
bedtime, 167 mg/dL.
Your first intervention for A.J. is that she should:
A-Test a 2 to 3 AM blood sugar to ascertain if she is having low blood sugar reactions
in the middle of the night, which is likely
B-Be testing her blood sugar 2 hours after her evening meal to ascertain if her blood
sugar is high
C-Increase the morning insulin lispro dose (by changing the insulin ratio with
breakfast)
D-Increase her glargine insulin to lower the fasting plasma glucose readings
E-Not be taking insulin lispro; it is better to switch her to insulin glulisine
208-X.M. is a 64-year-old African American male who has had type 2 DM for 22
years. Currently to control his blood sugar he takes 70/30 insulin twice daily before
breakfast and his evening meal. His average glucose readings over the last 2 weeks
(taken prior to meals and at bedtime )- are as follows:
morning, 99 mg/dL;
noon, 103 mg/dL;
afternoon, 62 mg/dL;
bedtime, 180 mg/dL.
Your first intervention is to:
210-The only medication recommended by the American Diabetes Association for the
prevention of diabetes is:
A-Metformin
B-Acarbose
C-Orlistat
D-Rosiglitazone
E-None of the above
211-A person with diabetes mellitus has had two urine microalbumin/creatinine ratios
of 35 and 45 mcg/mg with no other transient reasons to have these microalbumin
readings. The correct intervention at this time is to:
212-A person with diabetes mellitus, currently with excellent glycemic control,
presents to your clinic. A workup is done including a nerve conduction study, and it is
ascertained that the patient likely has peripheral neuropathy caused by diabetes. You
interview the patient and find numbness in the feet but no pain. You decide to:
A-Do nothing, as you do not treat numb variant peripheral neuropathy if glycemic
control is excellent
B-Start gabapentin 300 mg three times daily and titrate to 900 mg three times daily as
tolerated as it has been shown to be superior to duloxetine treatment
C-Allow glucose control to get slightly worse, as this has been documented to lessen
symptoms
D-Start duloxetine 60 mg at bedtime, as it has been shown to be superior to gabapentin
treatment
213-A subject with type 2 DM is referred to you for evaluation of diabetes. Currently
this patient takes no medications and has no allergies. The laboratory examination
results reveal the following:
Sodium (NA- = 140 mmol/L
Potassium (K) = 4.4 mmol/L
Blood urea nitrogen (BUN) = 13 mg/dL
Creatinine (Cr) = 0.5 mg/dL
Chloride (Cl) = 101mmol/L
FBG = 220 mg/dL
Fasting lipid profile:
Total cholesterol (TC- = 228 mg/dL
Low-density lipoprotein (LDL) = 138 mg/dL
High-density lipoprotein (HDL) = 40 mg/dL
Triglyceride (TG) = 250 mg/dL
Urinalysis = WNL
501 MCQs \ REVIEW IN CLINICAL PHARMACY Dr. Hassan AL-Temimi 47
HbA1c =9.1%
Your interventions are:
214-Monitoring of the pharmaceutical care plan for the patient with diabetes
includes all of the following except:
A-Hashimoto’s thyroiditis
B-Radioactive iodine therapy
C-Pituitary failure
D-Beta-blocker therapy
E-Over-treatment with thionamides.
222-Which are the following is NOT true about levothyroxine (synthetic thyroid
hormone?
223-Which are the following is NOT true about liothyronine (synthetic T3)?
A-It has a half-life of about one day, which means it has to be administered several
times a day to maintain steady levels of T3.
B-It has been used in combination with levothyroxine therapy
C-It produces stable serum levels of both T4 and T3.
D-The side effects can include palpitations and insomnia.
E-It is not the treatment of choice for hypothyroidism.
224-Which of the following are not true regarding the use of recombinant hTSH
(rhTSH)
A-rhTSH can be used to prepare patients with thyroid cancer for diagnostic
radioiodine whole body scanning.
B-rhTSH cannot be used to stimulate thyroglobulin production as part of the
diagnostic testing of patients with thyroid cancer.
C-Preparation with rhTSH avoids the morbidity of hypothyroidism.
D-rhTSH is given as an intramuscular injection.
E-Post-thyroidectomy adjuvant radioiodine therapy can be delivered following rhTSH
administration.
F-The sensitivity of diagnostic testing using radioiodine scanning and thyroglobulin
measured after withdrawal from thyroid hormone and after rhTSH are similar.
A-Growth
B-Thyroid function
C-Ovulation
D-Uterine contraction
A-Diarrhea
B-Increased shoe size
C-Weight loss
D-Alopecia
227-The preferred initial treatment option for a patient recently diagnosed with
acromegaly is:
A-Bromocriptine
501 MCQs \ REVIEW IN CLINICAL PHARMACY Dr. Hassan AL-Temimi 50
B-Lanreotide
C-Transsphenoidal surgery
D-Radiation therapy
228-K.L. a 58-year-old man who was recently diagnosed with acromegaly. His past
medical history is significant for type 2 diabetes and obesity. He is currently
complaining of fatigue, joint pain, increased sweating and headaches. Which of the
following medical treatments is most appropriate for first-line treatment of K.L.’s
symptoms?
A-Bromocriptine
B-Cabergoline
C-Octreotide
D-Pegvisomant
A-Alkaline phosphatase
B-Blood glucose
C-Thyroid function
D-All of the above
A-Menstrual irregularities
B-Darkened skin
C-Dry mouth
D-Increased blood glucose
A-Beta-blockers
B-Antidepressants
C-Antihistamines
D-Oral contraceptives
A-Radiation therapy
B-Transsphenoidal surgery
C-Dopamine agonist therapy
D-Somatostatin analog therapy
A-Cabergoline
B-Pergolide
C-Bromocriptine
D-Pramipexole
A-Thyroid replacement
B-Recombinant human growth hormone
C-Glucocorticoids
D-All of the above
240-A male patient complains that he is unable to have satisfactory intercourse with
his wife because his penis cannot get erect. This patient has which type of sexual
dysfunction?
A-Decreased libido
B-Erectile dysfunction
C-Premature ejaculation
D-Retrograde ejaculation
E-Infertility
A-Acetylcholine
B-Serotonin
C-Dopamine
D-Histamine
E-Aspartate
242-The Second Princeton Consensus Conference provides guidelines for the use
of this medical treatment for erectile dysfunction:
C-Alprostadil
D-Papaverine
E-Phentolamine
A-They are indicated in patients who complain of erectile dysfunction and have
normal serum testosterone concentrations.
B-They can cause leukopenia and thrombocytopenia.
C-An ideal regimen would mimic the normal physiologic secretion pattern of
testosterone, which is associated with peak concentrations in the evening.
D-Transdermal testosterone products bypass first-pass hepatic catabolism.
E-Oral alkylated derivatives of testosterone are not preferred because they have a short
duration of action.
249-An advantage of testosterone gel over the nonscrotal skin patch is that the
gel:
E-Penile prosthesis
253-Which one of the following statements about the natural history of benign
prostatic hyperplasia (BPH) is correct?
A-All patients with microscopic disease will eventually develop symptomatic disease.
B-BPH symptoms typically develop in men beginning at age 30 years.
C-All men who live to age 80 years will require a prostatectomy for symptom control.
D-Men with mild BPH symptoms may not require specific treatment.
E-All patients with symptomatic disease have an enlarged prostate.
254-A 60-year-old man with moderate BPH symptoms and a prostate size of 25 g
seeks treatment. He has essential hypertension, which is controlled with sodium
restriction, exercise, and weight control. The best initial choice for management
would be
A-Watchful waiting
B-a-Adrenergic antagonist
C-5a-Reductase inhibitor
D-a-Adrenergic receptor antagonist plus 5a-reductase inhibitor
E-Surgery
255-A 70-year-old man presents with severe BPH symptoms and a history of
persistent severe, gross hematuria, and recurrent urinary tract infection. The best
treatment would be
A-Watchful waiting
B-a-Adrenergic antagonist
C-5a-Reductase inhibitor
D-a-adrenergic receptor antagonist plus 5a-reductase inhibitor E-Surgery
256-A patient with decreased force of urinary stream and mild BPH symptoms
presents for treatment. His prostate size is 25 g. The best treatment would be
A-Watchful waiting
B-a-Adrenergic antagonist
C-5a-Reductase inhibitor
D-a-Adrenergic receptor antagonist plus 5a-reductase inhibitor E-Surgery
A-Terazosin
B-Alfuzosin
C-Doxazosin
D-Tamsulosin
E-Prazosin
261-At the time of diagnosis, a patient with BPH has a PSA of 2 ng/mL. Six months
after initiating treatment with finasteride 5 mg orally daily, a repeat PSA is 1 ng/mL.
Based on this laboratory test result, the following action should be taken:
A-Discontinue finasteride.
B-Continue finasteride 5 mg daily
C-Increase finasteride to 10 mg daily
D-Switch to dutasteride 0.5 mg daily
E-Switch to tamsulosin 0.4 mg daily
262-A patient with BPH is receiving tamsulosin. He needs to undergo cataract surgery
in 4 weeks. The patient informs his ophthalmologist that he is taking tamsulosin.
The ophthalmologist should
A-Cancel surgery
B-Hold tamsulosin for 2 weeks prior to surgery
C-Hold tamsulosin for 1 day prior to surgery
D-Take precautions during surgery
E-Discontinue tamsulosin postoperatively
501 MCQs \ REVIEW IN CLINICAL PHARMACY Dr. Hassan AL-Temimi 57
263-A patient has BPH for which he is receiving doxazosin. He now sees his doctor
for new-onset erectile dysfunction, for which he is prescribed sildenafil. The
pharmacist should counsel the patient to
A-Decreased libido
B-Increased libido
C-Erectile dysfunction
D-Ejaculation disorder
E-Infertility
265-For patients with BPH, the reason for the addition of tolterodine to
tamsulosin is to
A-Phosphodiesterase
B-ATPase
C-5a-Reductase
D-Serotonin
E-Dopamine
271-For bladder over activity, which drug class constitutes the treatment of
choice in the majority of cases?
A-Tricyclic antidepressants
B-Estrogens
C-alpha-Adrenergic receptor agonists
D-Anticholinergics
E-Bethanechol
A-Anticholinergics
B-Oral estrogens
C-Topical (vaginal) estrogens
D-Dual-reuptake inhibitors
E-?-Adrenergic receptor agonists
A-Oxybutynin
B-Tolterodine
C-Flavoxate
D-Fesoterodine
E-Trospium chloride
275-Which one of the following is the preferred agent for the treatment of
urethral underactivity?
A-Ephedrine
B-Pseudoephedrine
C-Phenylpropanolamine
D-Midodrine
E-Duloxetine
A-Imipramine
B-Oxybutynin
C-Tolterodine
D-Solifenacin
E-Any of the above
278-Periurethral injections are most useful for which one of the following?
279-Kegel (pelvic floor muscle- exercises are indicated in which of the following
circumstances?
A-Overflow (obstructive- urinary incontinence
B-Stress urinary incontinence
C-Urge urinary incontinence
D-Overflow (poorly contractile- urinary incontinence
E-Both B and C are correct
280-Urethral underactivity can be associated with all of the following risk factors
except which one?
A-Childbirth
B-Radical prostatectomy
C-Surgery for benign prostatic hyperplasia
D-alpha-Adrenergic receptor antagonist therapy of hypertension
E-All of the above can be associated with urethral underactivity
A-Diuretics
B-alpha-Adrenergic receptor antagonists
C-Calcium channel blockers
D-Angiotensin-converting enzyme inhibitors
E-Angiotensin receptor blockers
282-Which one of the following would be the best pharmacotherapy option for a
75-year-old male with bladder over activity and mild Alzheimer disease who is
currently taking donepezil?
A-Imipramine
B-Oral oxybutynin
C-Tolterodine
D-Topical oxybutynin
E-All of the above can be difficult to use because of pharmacologic antagonism
A-131 mOsm/kg
B-185 mOsm/kg
C-251 mOsm/kg
D-280 mOsm/kg
E-355 mOsm/kg
285-Both plasma osmolality and effective circulating volume influence AVP release
from the posterior pituitary, thereby influencing the reabsorption of water in the
collecting ducts. What direction of change in these two variables stimulates
increased release of AVP?
286-C.D. is a 64-year-old man with trigeminal neuralgia who has been diagnosed with
carbamazepine-induced syndrome of inappropriate antidiuretic hormone (SIADH).
What clinical and laboratory findings would be consistent with this diagnosis?
A-Clinical hypovolemia
B-Clinical hypervolemia
C-Maximally dilute urine
D-Urine sodium concentration >20 mEq/L
E-Urine sodium concentration <20 mEq/L
A-Muscular weakness
B-Restlessness
C-Diarrhea
D-Cardiac arrhythmias
E-Bronchospasm
A-Cardiovascular
B-Gastrointestinal
C-Nervous
D-Pulmonary
E-Urinary
501 MCQs \ REVIEW IN CLINICAL PHARMACY Dr. Hassan AL-Temimi 63
A-Swelling
B-Dehydration
C-Exsanguination
D-Degeneration
294-J.S. is a 36-year-old man whose bipolar disorder has been treated with lithium for
several years. He now reports that he has had to urinate more frequently than normal
over the past several weeks. This has been getting progressively worse and has been
accompanied by increasing thirst. The patient’s serum sodium is 146 mEq/L and his
24-hour urine output is 5 liters. What is an appropriate treatment of this patient’s
condition?
296-Which diuretic has the greatest ability to increase the fractional excretion of
sodium?
A-Hydrochlorothiazide
B-Furosemide
C-Metolazone
D-Spironolactone
E-Acetazolamide
297-J.V. is a 68-year-old man with severe congestive heart failure who currently lives
at home with his wife. His GFR is 60 mL/min. J.V.’s physician has progressively
increased his dose of furosemide to 120 mg every 6 hours to control his edema,
without success. What is the most appropriate change to this patient’s diuretic
therapy at this point?
A-Increasing the dose of furosemide
B-Switching to a continuous infusion of furosemide
501 MCQs \ REVIEW IN CLINICAL PHARMACY Dr. Hassan AL-Temimi 64
C-Adding metolazone
D-Adding torsemide
298-A 72 year old female with a past medical history of hypertension and type 2
diabetes mellitus presents with fatigue, bone pain and feeling weak. On examination
there is evidence of bony tenderness in her spine and legs and proximal muscle
weakness. Bloods reveal elevated creatinine, phosphate and parathyroid hormone
levels and a low calcium. Which of the following should be commenced?
A-.Cholecalciferol
B- Cinacalcet
C-Alfacalcidol
D- Risedronate
E-Strontiumranelate
A- Atenolol
B- Amlodipine
C- IsosorbideMononitrate
D- Nicorandil
E- Diltiazem
A- Carvedilol
B- Digoxin
C- Nitrates and hydralazine
D- Ramipril
E- Spironolactone
301-A patient presents with compensated cardiac failure. Which of the following
medications is commenced initially and will most likely improve symptoms and
prognosis?
A- Furosemide
B-Spironolactone
C-Digoxin
D-Amlodipine
E-Ramipril
A- Factor IX
B- Factor X
C- Factor VII
D- Factor II
E- Factor VIII
A- Hepatotoxicity
B- Peripheral Neuropathy
C- Nausea
D- Treatment failure
E- None of these
305-A patient has recently underwent a liver transplant and is found to have
hyperkalaemia. He is on anti rejection drugs but is otherwise well and is on no other
medications. What is the most likely cause of his hyperkalaemia?
A- Ramipril
B- Tacrolimus
C- None of these
D- Ciclosporin
E- NSAIDs
306-A patient who has recently undergone a renal transplant presents with excessive
hair growth.
Which of the following medications is the most likely cause?
A- Azathioprine
B- Corticosteroids
C-Mycophenolatemofetil
D-Ciclosporin
E-Tacrolimus
501 MCQs \ REVIEW IN CLINICAL PHARMACY Dr. Hassan AL-Temimi 66
A- Atenolol
B- Losartan
C- Labetalol
D- Ramipril
E- Bendroflumethiazide
308-A 72 year old male with type 2 diabetes mellitus is found to be hypertensive. Over
the last few months there has been protein in his urinalysis persistently. You decide to
commence an antihypertensive. Which of the following is the most appropriate?
A- Amlodipine
B- Atenolol
C- Losartan
D- Ramipril
E- Bendroflumethiazide
310-A patient is found to have a broad complex tachycardia. Which of the following
is contraindicated?
A- Verapamil
B- DC Cardioversion
C- Lidnocaine
D- Amiodarone
E- Adenosine
A- Spironolactone
B- Furosemide
C- Amiloride
D- Bendroflumethiazide
E- Ramipril
A- Dopamine antagonist
B- Dopamine agonist
C- 5-HT1D receptor antagonist
D- 5-HT1D receptor agonist
E- Calcium channel blocker
313-A patient with rheumatoid arthritis presenting with increasing dyspnea. Which of
the following drugs is most likely responsible?
A- Gold
B- Methotrexate
C- NSAIDs
D- Hydroxychloroquine
E- Sulphasalazine
314-A 68 year old male is being treated for a UTI. He suffers an Achilles tendon
rupture. Which of following antibiotic is he most likely to be taking?
A- Coamoxiclav
B- Amoxicillin
C- Ciprofloxacin
D- Trimethoprim
E- Nitrofurantoin
315- In angina, which of the following accounts for some of the therapeutic effect
of beta blockers?
316-A 19 year old is brought to A+E. He was on a night out 2 nights ago and is
described by his friend as a "party animal". He is now acting very oddly. He is clearly
hallucinating and is speaking rapidly. He is euphoric and laughing inappropriately. He
appears agitated and his affect is blunted. His pupils are dilated and he is tachycardic.
What is the most likely diagnosis?
A- Heroin use
B- Cannibas induced psychosis
C- Bipolar disorder
D- Schizophrenia
E- Amphetamine induced psychosis
501 MCQs \ REVIEW IN CLINICAL PHARMACY Dr. Hassan AL-Temimi 68
317- A 45 year old patient who is known to drink excessively presents in acute alcohol
withdrawal. On examination he appears malnourished. He is commenced on diazepam.
His BM is 4.2mmol/l. What is the next course of action?
A- IM glucagon
B- IV dextrose
C- Commence IV Thiamine
D- Liaison psychiatry
E- IV magnesium
318-A patient with a 6-months history of low mood and some suicidal thoughts is
discussing her treatment options. Which of the following is the best
pharmacological treatment?
A- Amitriptyline
B- Selegiline
C- Lorazepam
D- Haloperidol
E- Fluoxetine
A- Haloperidol
B- Diazepam
C- Doxylamine
D- Temazepam
E- Chlorpromazine
320-A newborn baby has thin lips, a smooth philtrum, small eyes and a small head.
Whilst examining him he suffers a seizure. What is the diagnosis?
A- Naltrexone
B- Nalorphine
C- Oxymorphone
D- Naloxone
E- Buprenorphine
501 MCQs \ REVIEW IN CLINICAL PHARMACY Dr. Hassan AL-Temimi 69
A- Noradrenaline
B- Serotonin
C- GABA
D- Adenosin
E- Histamine
A-Quetiapine
B-Clozapine
C-Lorazepam
D-Haloperidol
E-Diazepam
326-If lithium fails, what is the next treatment of choice for bipolar syndrome?
A-Oxcarbazepine
B- Risperidone
C- Valproate
D- Imipramine
E- Quetiapine
E- Clozapine
331-A 58 year old male with COPD, has been admitted several times over the last 6
months with non-infective exacerbation of COPD. He is currently on seretide. Which
of the following is the next appropriate stage in management?
A- Nebulized salbutamol
B- Tiotropium
C- Ipratropium
D- Maintenance dose oral steroids
E- Salbuatmol Prn
332-A 32 year old presents with a one week history of malaise, fever, headache,
myalgia with a sore throat, dry cough and pleuritic chest pain. On examination there is
501 MCQs \ REVIEW IN CLINICAL PHARMACY Dr. Hassan AL-Temimi 71
A- Co amoxiclav
B- Doxycycline
C- Erythromycin
D- Amoxicillin
E- Ciprofloxacin
A- Pyrazinamide
B- Rifampicin
C- Isoniazid
D- Ethambutol
E- Streptomycin
335-A 52 year old gentleman has been unwell for the last couple of weeks with a viral
illness. He is now very unwell with a high grade fever, productive cough and type 1
respiratory failure. A chest X-ray reveals multilobular patchy consolidation. There is
also evidence of a pleural effusion. Given the most likely causative agent, which
antibiotic is a useful addition?
A- Flucloxacillin
B- Metronidazole
C- Ceftriaxone
D- Erythromycin
E-Doxycycline
336-A 28 year old female with asthma which is normally well controlled presents with
worsening wheeze. She states this is associated with a productive cough and on
occasion the sputum has been blood stained. This is also associated with malaise and
severe headache. This has occurred on several occasions over the last few months. Her
family owns a farm. As her father died recently she has been helping out on the farm.
Bloods reveal an eosinophilia and raised IgE. A CXR shows evidence of pulmonary
infiltrates. Given the most likely diagnosis, what treatment should be commenced?
501 MCQs \ REVIEW IN CLINICAL PHARMACY Dr. Hassan AL-Temimi 72
A-Salbutamol inhaler
B- Azathioprine
C- Nil specific
D- Prednisolone
E- Amoxicillin
337-A 25 year old female has an acute asthma attack. She is tachycardic and is
tachypnoeic with a respiratory rate of 35. On auscultation she is very wheezy but is
beginning to tire. Her peak flow is bout one third of her normal. She is commenced on
both salbutamol and ipratropium nebulizers and IV hydrocortisone however has not
greatly improved. Her gases reveal a high normal CO2 level and low normal O2 level
on a trauma mask. Which other treatment option is the most appropriate to be be
tried whilst waiting for ITU to assess the patient?
A- IV aminophylline
B- IV magnesium sulphate
C- CPAP
D- IV salbutamol
E- BiPAP
338-A 30 year old male with asthma who has a regular steroid inhaler and uses
salbutamol PRN, presents with worsening asthma. Despite his current management
and good inhaler technique, he is having to use his salbutamol inhaler approximately
four times a day. What is the next appropriate addition to his current medication?
A- Theophylline
B- Increased steroid dose
C-Trial of addition of long acting beta agonist
D- Sodium cromoglycate
E- Montelukast
A- Alcohol
B- Amoxicillin
C- Smoking
D- Carbamazepine
E- Clarithromycin
346-Acetaminophen :
501 MCQs \ REVIEW IN CLINICAL PHARMACY Dr. Hassan AL-Temimi 74
348-NSAIDs:
A-Are associated with thousands of serious or life-threatening GI adverse events every
year
B-Provide superior relief of OA pain in some individuals
C-Will usually produce symptoms of dyspepsia or abdominal discomfort as a prelude
to serious GI adverse events
D-When used in anti-inflammatory doses, should be consistently monitored by serum
levels
E-a and b
349-NSAIDs :
351-Intraarticular corticosteroids
A-Have no role in OA, as this disease does not have any inflammatory component
B-Are recommended as maintenance therapy for patients who can not tolerate
NSAIDS and who have severe OA
C-Can be administered up to 12 times per year for the treatment of severe OA pain
501 MCQs \ REVIEW IN CLINICAL PHARMACY Dr. Hassan AL-Temimi 75
A-Nonselective NSAIDs used at analgesic doses, if the patient is not at high risk for
GI bleeding
B-Nonselective NSAIDs with an H2 antagonist to prevent GI bleeding in the high-risk
patient
C-COX-2–selective inhibitors with sucralfate in the high-risk patient
D-COX-2–selective inhibitors with misoprostol in the high-risk patient
E-None of the above
B-Nephrolithiasis
C-Osteoarthritis
D-Gouty nephropathy
E-Tophaceous gout
359-Which of the following is the most likely site for acute mono-articular gouty
arthritis?
360-All of the following are risk factors for uric acid nephrolithiasis except
A-Hyperuricemia
B-Alkaline urine
C-Highly concentrated urine
D-Increased urinary excretion of uric acid
E-Uricosuric therapy
362-Serum urate concentrations are correlated with all of the following except
A-Alcohol intake
B-Body weight
C-Increasing age
D-Serum cholesterol
E-Blood pressure
501 MCQs \ REVIEW IN CLINICAL PHARMACY Dr. Hassan AL-Temimi 77
A-Axonal neuromyopathy
B-Constipation
C-Renal toxicity
D-Hepatotoxicity
E-Bone marrow toxicity
365-The preferred treatment option for a patient with acute gouty polyarticular
arthritis who presents 36 hours after the onset of pain is ?
A-Allopurinol
B-Sulfinpyrazone
C-Colchicine
D-Naproxen
E-Triamcinolone intra-articular injection
370-The preferred treatment option for a patient with polyarticular acute gouty
arthritis of 3 days duration who can not tolerate an NSAID is?
A-Intravenous colchicines
B-Corticosteroids
C-Oral colchicine
D-Probenecid
E-Sulfinpyrazone
372-Which of the following has been shown to be safe to use during pregnancy in
a women with SLE?
A-Methotrexate
B-Chlorambucil
C-Hydroxychloroquine
D-Cyclophosphamide
373-Which of the following are the most common symptoms for drug-induced
lupus?
A-Psychosis
B-Musculoskeletal
C-Depression
D-Nephritis
501 MCQs \ REVIEW IN CLINICAL PHARMACY Dr. Hassan AL-Temimi 79
A-Prednisone
B-Hydroxychloroquine
C-Methotrexate
D-D-penicillamine
A-Prednisone
B-Hydroxychloroquine
C-Methotrexate
D-D-penicillamine
A- Filtration
B- Reabsorption
C- Secretion
D- Endocytosis
377-Active drug secretion occurs most often in which of the following nephron
segments:
A- Glomerulus
B- Proximal tubule
C- Loop of Henle
D- Distal tubule
378- According to the intact nephron hypothesis, reabsorption ______ and single
nephron GFR ______ in the surviving nephrons:
A- increases, increases
B- decreases, decreases
C- increases, decreases
D- decreases, increases
379-The kidney is responsible for synthesizing each of the following hormones,
EXCEPT:
A- Erythropoietin
B- Prostaglandin
C- PTH
D- Renin
A- analytical interference
B- increased tubular secretion of creatinine
C- increased GFR caused by dobutamine
D- increased muscle breakdown
381- Which of the following renal function indices is least influenced to changes in
fluid or volume status:
A- Serum creatinine
B- Blood urea nitrogen
C- Urine specific gravity
D- Urine sodium
A- Serum creatinine
B- Blood urea nitrogen
C- Creatinine clearance .
D- Urine sodium
A-Iohexol clearance
B-Iothalamate clearance
C-Inulin clearance
D-Creatinine clearance
385- J.R. is a 68 year-old Caucasian man (60 kg, 5’7”) with a history of hypertension,
cerebral stroke and benign prostatic hypertrophy. He presents to the ambulatory care
clinic today for evaluation of a viral infection to be treated with acyclovir. His serum
creatinine value today is 0.63 mg/dL. Which one of the following approaches
should be used to assess this patient’s renal function for the purpose of renal dose
adjustment for acyclovir?
386 -An appropriate clinical monitoring plan to evaluate renal protective therapy
in patients with CKD should include each of the following items EXCEPT:
387- In the clinical setting, the renal clearance of PAH is considered an index of
_______.
388-Which of the following is the least common type of true acute kidney injury
(AKI)?
A- Prerenal AKI
B- Pseudorenal AKI
C- Intrinsic AKI
D- Postrenal AKI
389-A 60-year-old long-term care resident is admitted to the hospital with altered
mental status. His admission laboratory values show a blood urea nitrogen (BUN) of
30 mg/dL (10.7 mmol/L), serum creatinine (Scr) of 2 mg/dL (177 µmol/L), a fractional
excretion of sodium (FeNa- of 2.5% (0.025), and granular casts on urine sediment.
The most likely etiology of his AKI is?
390-Which of the following parameters are used to determine the stage of severity
of a patient’s AKI by means of Risk, Injury, Failure, Loss of Kidney Function,
and End-Stage Renal Disease (RIFLE- and Acute Kidney Injury Network
(AKIN) classification systems?
391-A 56-year-old (71 kg) man is admitted to the intensive care unit with sepsis. His
serum creatinine increased from a baseline of 0.9 mg/dL (80 µmol/L) to 1.6 mg/dL
(141 µmol/L), and his blood urea nitrogen (BUN) increased from 15 mg/dL (5.4
mmol/L) to 30 mg/dL (10.7 mmol/L). His urine output in the last 24 hours was 500
mL. Per RIFLE criteria, which stage does this patient’s AKI belong to?
A- Risk
B- Injury
C- Failure
D- Loss of kidney function
E- End-stage kidney disease
393-A 66-year-old woman with a history of diabetes and chronic kidney disease is
scheduled for diagnostic imaging requiring contrast dye administration. Her serum
creatinine is 2 mg/dL (177 µmol/L), blood urea nitrogen (BUN) is 30 mg/dL (10.7
mmoL/L), and urine output in the last 24 hours is 1,500 mL. Her complete blood count
and electrolytes are all within normal range. Which of the following medications
would you recommend to decrease the risk of contrast-induced nephropathy in
this patient?
394-Which of the following medications should not be used for prevention of AKI
in high-risk individuals?
A- Ascorbic acid
B- Sodium bicarbonate
C- Dopamine
D- N-acetylcysteine
A- Saline hydration
B- Intermittent hemodialysis
C- Continuous renal replacement therapy
D- None of the above; supportive care is the mainstay of therapy
A- Hypophosphatemia
B- Hyperkalemia
C- Hyponatremia
D- None of the above; electrolytes are usually unaffected
400-All of the following factors can make drug dosing a challenge in a critically ill
patient with established AKI except the ?
A- Presence of edema, which can significantly increase the volume of distribution of a
drug
B- Presence of residual non-renal clearance
C- Need for constant reassessment of the patient’s renal function and status
D- Presence of electrolyte abnormalities
A- Valsartan
B- Acyclovir
C- Lithium
D- Gentamicin
A- Metolazone alone
B- Hydrochlorothiazide + metolazone
C- Furosemide + metolazone
D- Furosemide + spironolactone
406-Which of the following is the recommended total daily energy intake for a
patient with ESRD on chronic hemodialysis?
407-A patient with ESRD and the associated secondary complications would
likely present with which of the following laboratory data?
A- Intravenous
B- Oral
C- Either oral or intravenous
D- Intramuscular
409-Achievement of a higher target hemoglobin level (> 12 g/dL [>120 g/L; 7.45
mmol/L]) in the CKD population has been associated with which of the following?
412-Which of the following iron preparations requires a test dose because of the
association with anaphylactic reactions?
A- Iron dextran
B- Sodium ferric gluconate
C- Iron sucrose
D- Ferumoxytol
414-TR is an ESRD patient just starting peritoneal dialysis. The most recent laboratory
analysis reveals the following:
phosphorus 7.4 mg/dL (2.39 mmol/L),
calcium 9.0 mg/dL (2.25 mmol/L),
albumin 2.5 g/dL (25 g/L), iPTH 500 pg/mL (500 ng/L),
25-OH D 40 ng/mL (100 nmol/L).
TR is on sevelamer carbonate as a phosphate binder and no other therapy to address
CKD-MBD. Which of the following is the most appropriate vitamin D therapy?
A- Calcitriol
B- Ergocalciferol
C- Paricalcitol
D- Cholcalciferol
415- In addition to lowering PTH, the calcimimetic agent cinacalcet causes which
of the following changes in laboratory parameters?
A- Proteinuria
B- Pyuria
C- Hematuria
D- A decline in the glomerular filtration rate (GFR)
E- A reduction in tubular secretion
419-Which of the following drugs would be the most likely culprit in a patient
with newly diagnosed renal intratubular obstruction?
A-Ibuprofen
B-Losartan
C-Amphotericin B
D-Ciprofloxacin
E-Acyclovir
421-Which of the following drugs has been associated with chronic interstitial
nephritis?
A-Cyclosporine
B-Ifosfamide
C-Lithium
D-Streptozotocin
E-All of the above
A-Propylthiouracil
501 MCQs \ REVIEW IN CLINICAL PHARMACY Dr. Hassan AL-Temimi 88
B-Aminoglycosides
C-Pamidronate
D- Radiographic contrast media
E- Hydralazine
A- Amifostine
B- Acetylcysteine
C- Low-osmolality agents
D- Hydration
E- Reduced doses of contrast
E- "Once daily" dosing may be one method to maintain antimicrobial efficacy while
reducing nephrotoxicity.
432-In a patient with nephrotic syndrome, which of the following is not expected
to be present?
A-Proteinuria
B-Edema
C-Hyperlipidemia
D-Hypercoagulable state
E-Hematuria
433-Which of the following is not expected to reduce proteinuria when used for
patients with glomerulonephritis?
501 MCQs \ REVIEW IN CLINICAL PHARMACY Dr. Hassan AL-Temimi 90
A- Minimal-change nephropathy
B- Focal segmental glomerulonephritis
C- Membranous nephropathy
D- Immunoglobulin A nephropathy
E- Membranoproliferative glomerulonephritis
A- Minimal-change nephropathy
B- Focal segmental glomerulonephritis
C- Immunoglobulin A nephropathy
D- Membranous nephropathy
E- Membranoproliferative glomerulonephritis
A- Steroid
B- Cyclosporine
C- Azathioprine
501 MCQs \ REVIEW IN CLINICAL PHARMACY Dr. Hassan AL-Temimi 91
D- Cyclophosphamide
E- Levamisole
439-Which of the following is not correct regarding the use of cyclosporine for the
treatment of minimal-change nephropathy?
A. Thiamine supplements
B. Clonazepam
C. Phenytoin
D. Minoxidil
E. Renal transplant
443- Fish oil may be beneficial in certain patients with which of the following
types of glomerulonephritis?
A- Minimal-change nephropathy
B- b. Focal segmental glomerulonephritis
C- Immunoglobulin A nephropathy
D- Membranous nephropathy
501 MCQs \ REVIEW IN CLINICAL PHARMACY Dr. Hassan AL-Temimi 92
E- Membranoproliferative glomerulonephritis
445-A patient with IgA nephropathy who has normal renal function, isolated
micro-hematuria, and proteinuria less than 1 g/day should be:
446-Which of the following is not normally considered when selecting the optimal
treatment for patients with lupus nephritis?
A- Type of underlying lesion
B- Disease activity according to pathologic findings
C- Severity of symptoms
D- Duration of symptoms
E- All of the above are commonly considered
A- Steroid
B- Cytotoxic agent
C- Cyclosporine
D- Mycophenolate mofetil
E- Fish oil
448-Monoclonal antibodies have been evaluated for the treatment of which of the
following glomerular disease?
A- Minimal-change nephropathy
B- Focal segmental glomerulonephritis
501 MCQs \ REVIEW IN CLINICAL PHARMACY Dr. Hassan AL-Temimi 93
C- IgA nephropathy
D- Lupus nephritis
E- Poststreptococcal glomerulonephritis
A- Group A streptococci
B- Hepatitis C virus
C- HIV
D- Parasites
E- All of the above
A-Loratadine
B-Diphenhydramine
C-Montelukast
D-Levocetirizine
E-Cetirizine
A-Vasoconstriction
B-Reduction in erectile tissue size
C-Airway widening
D-Vasodilation
E-All of the above except d
A-Cytokines
B-Histamine
C-Leukotriene C4
D-Prostaglandin D2
E-Tryptase
501 MCQs \ REVIEW IN CLINICAL PHARMACY Dr. Hassan AL-Temimi 94
A-Cetirizine
B-Cyproheptadine
C-Loratadine
D-Diphenhydramine
E-Chlorpheniramine
455-For a patient receiving nasal steroids, which of the following agents would be
helpful for a patient that also had ocular symptoms?
A-Azelastine
B-Levocabastine
C-Pseudoephedrine
D-Phenylephrine
E-Montelukast
A-Topical decongestants
B-Systemic decongestants
C-Nasal steroids
D-Nasal antihistamines
E-Cromolyn sodium
A-Anaphylaxis
B-Bronchospasm
C-Swelling at the injection sit
D-Generalized urticaria
E-All of the above
A-2 years
B-1 year
C-6 months
D-2 months
E-Newborns
A-ß1 specificity
B-Intrinsic sympathomimetic activity
C-Available dosage forms
D-Frequency of local and systemic side effects
E-all of the above
A-Corticosteroids
B-Azathioprine
C-ß-Adrenergic blocker
D-Thiazide diuretics
A-Oral contraceptives
B-Verapamil
C-Valproic acid
D-Clarithromycin
A-Etanercept
B-Alefacept
C-Adalimumab
D-Infliximab
471-Appropriate use of oral prednisone for atopic dermatitis includes all of the
following except:
472- Which of the following does not have a role in the management of chronic
cancer pain?
A- Carbamazepine
B- Clodrinate
C- Dexamethasone
D- Nifedipine
E- Pinavarium
473- A 17 year old girl was found collapsed and drowsy. Her 12-lead ECG showed a
sinus tachycardia of 120 beats per minute with a corrected QT interval of 500 ms
(normal <470). Which of the following is the most likely cause of her presentation?
A- Amphetamine
B-Diphenhydramine
C-Glue sniffing
D-Methadone
E- Methanol
474- A 70-year-old woman has a history of dyspnea and palpitations for six months.
An ECG at that time showed atrial fibrillation. She was given digoxin, diuretics and
aspirin. She now presents with two short-lived episodes of altered sensation in the left
face, left arm and leg. There is poor coordination of the left hand. ECHO was normal
as was a CT head scan. What is the most appropriate next step in management?
A- anticoagulation
B- carotid endarterectomy
C- clopidogrel
D- corticosteroid treatment
E- no action
475 -A 60-year-old man with a past history of controlled hypertension presents with
acute onset weakness of his left arm, that resolved over 12 hours. He had suffered two
similar episodes over the last three months. Examination reveals a blood pressure of
132/82 mmHg and he is in atrial fibrillation with a ventricular rate of 85 per minute.
CT brain scan is normal. What is the most appropriate management
A- amiodarone
B- aspirin
C- digoxin
D- dipyridamole
E- warfarin
476- A 30-year-old man presents with a history of transient loss of consciousness and
palpitations. His ECG shows ventricular tachycardia. Which of the following
treatments should be avoided?
A- adenosine
B- amiodarone
C- DC cardioversion
501 MCQs \ REVIEW IN CLINICAL PHARMACY Dr. Hassan AL-Temimi 98
D- flecainide
E- verapamil
477- A 56 year old male with left ventricular systolic dysfunction was dyspnoeic on
climbing stairs but not at rest. The patient was commenced on Ramipril and
furosemide. Which one of the following drugs would improve the patient's
prognosis?
A- Amiodarone
B- Amlodipine
C- Bisoprolol
D- Digoxin
E- Nitrate therapy
478- A 60-year-old Chinese man has been started on quinine for leg cramps by his
General Practitioner. He presents, a week later, with 5 days of darkened urine and 2
days of increasing breathlessness, back pain and fatigue. Investigations show a
hemoglobin of 7.0 g/dl and raised reticulocyte count. Which of the following best
explain this drug reaction?
A-autoimmune hemolytic anemia
B- glucose-6-phosphate dehydrogenase deficiency
C- hereditary spherocytosis
D- pyruvate kinase deficiency
E- sickle cell disease
497- A 23 year old male presents with a deep vein thrombosis. He has no past medical
history but his mother has suffered from deep vein thrombosis. Which of the
following is likely to be found on hematological assessment?
A- Neutralizing histamine.
B- Blocking H1- & H2 receptor site.
C- Promoting dilatation of the bronchioles.
D- Overcoming insufficiencies of the neutrally occurring hormone to suppress the
immune reaction.
483- After giving methylprednisolone, the paramedic should frequently asses the
patients for:
A- Tachyarrhythmia.
B- Peripheral edema.
C-Hypoglycemia.
D-Hypotension.
A- 100 – 500 mg
B-50 – 100 mg
C- 30 – 50 mg
D- 5 mg \ kg
485- In the situation described, you decide your patients has developed moderate
case of anaphylaxis. What are the drugs that medical controls likely to order
first?
A-Control of seizures.
B-Treatment oh hypertension.
C-Control of postpartum hemorrhage.
D-Treatment of sever bronchospasm.
487- A major concern in patients with eclampsia is seizures. The prehospital drug
of choice in the treatment of sever eclampsia is :
A-Oxytocin.
B-Magnesium sulfate.
501 MCQs \ REVIEW IN CLINICAL PHARMACY Dr. Hassan AL-Temimi 100
C- Diazepam.
D-Labetolol.
A-3 – 10 U IV.
B-1mg\ kg IV.
C-10 - 20 mg IV.
D-2 – 4 gm IV.
489- You are called to the home of woman " having seizures. "On arrival you find a
woman in her late 20s experiencing active seizures. The patients mother says that her
daughter is 7 month pregnant. She also report this is her daughters second seizures
since she called for help. Earlier in the day the patient had complained of sever
headache, dizziness, nausea, chest pain, & spots before her eyes. Seizures control for
this patients should begin with:
A-Diazepam.
B-Calcium gluconate.
C-Magnesium sulfate.
D-Oxytocin.
491- The organ most sensitive to the effects of thiamine deficiency is the:
A- Heart.
B- Liver.
C- Brain.
D- Kidney.
492- You respond to the home of unconscious, unresponsive female patients. Your
assessment finds the patients presenting with Kussmal respiration at 40\ min. The ECG
monitor shows sinus tachycardia at a rate of 120 bpm.Skin is warm& dry & the
patients has a fruity odor on her breath. Her blood pressure is low. This patients is
presenting with classic signs & symptoms of :
493- The pancreas is responsible for the production of insulin. Without insulin:
A- Hypoglycemia will result.
B- A build up of CO2 produces acidosis.
C- Starches cannot be metabolized in to glucose.
D- Glucose cannot be pass in to the body's cells.
495- The recommended initial dose for O2 when treating a patients with COPD
is:
A- 15L \ min.
B- 10L \ min.
C- 4 – 6 L \ min.
D- 2 – 3L \ min.
496- Bronchodilators are used to treat reversible airway obstruction. They work by:
A- Decreasing edema.
B- Reducing CO2 content.
C- Relaxing the bronchial smooth muscle.
D- Increasing breathing by stimulation of the CNS.
497- Why is dopamine one of the drug of choice for the treatment of
hemodynamically Significant hypotension in absence of hypovolemia?
I-Dopamine increases blood pressure & cardiac output.
II- Dopamine causes a decrease in preload.
III- Dopamine may decrease oxygen demand on the heart.
A- II & III
B- II & IV
C- I & II
D- I ,III & IV
A- I & II only
B- II & III only
C-II & IV only
D- All of the above.
501 MCQs \ REVIEW IN CLINICAL PHARMACY Dr. Hassan AL-Temimi 102
A- 180 mg
B- 100 mg
C- 82 mg
D- 50 mg
500- You are called to a 67 – years- old woman who say that her heart feels like it is "
fluttering." Your ECG monitor indicate the patients is experiencing paroxysmal
supraventricular tachycardia at regular rate of 180 bpm. Vital signs are currently
within normal limits & she is tolerating the rhythm fairly well. Which is the drug of
choice to treat stable paroxysmal supraventricular tachycardia?
A- Isoprotrenol.
B- Procainamide.
C- Nitroprusside.
D- Verapamil.
501- Chlorpromazine & haloperidol are classified as antipsychotic, and their use
is contraindicated for patients :
Answers
1-A-Low protein binding
2-C-Take folic acid 400 mcg daily throughout the reproductive years
3-C-Prednisone
4-C-Oral calcium supplementation
5-A-Ceftriaxone 250 mg IM as a single dose
6- B-Macular damage
7-A-Switch drug therapy to Phenobarbital
8- E-Propranolol
9- D-Continue current treatment regimen
10-C-Promote fetal lung maturity in premature infants
11-B-Intravaginal misoprostol
12-E-Diet modification
13-D-Maternal fatality
14-C-High protein binding
15-D-Cephalexin 500 mg orally every 6 hours for 14 days
16-B-Progestin-only oral contraceptive
17-A-Smoking increases the risk of venous thromboembolism.
18-C-Wait another 1 to 2 months to see if symptoms improve on their own
19-B-Depo-medroxyprogesterone acetate
20-B-Buy emergency contraception
21-D-Do a pregnancy test and if negative give the injection today
22-B-Hypertension treated with a diuretic and an average blood pressure of 172/92
mm Hg
23-B-Pelvic inflammatory disease
24-B-Take an active tablet as soon as possible (two tablets on that day) and then
continue taking tablets daily, one each day. Use condoms or abstain from sex until
tablets have been taken for 7 days in a row. Finish the active tablets in the current pack
and start a new pack the next day (i.e., do not take the seven inactive tablets).
25-A-Those with pelvic inflammatory disease within the last 3 month
26- D-Production of thick cervical mucous
27-A-Have history of antiphospholipid syndrome and history of deep vein thrombosis
28-A-30-year-old woman with hypothyroidism
29-D-Levonorgestrel emergency contraception can be taken as a single dose (1.5 mg)
within 72 hours of unprotected intercourse
30- B-Transdermal contraceptive
31- A-Perform a pregnancy test
32- B-Increase the intake of dietary calcium and vitamin D
33-C-Medroxyprogesterone acetate 10 mg by mouth for 10 days
34-B-Mefenamic acid 500 mg by mouth followed by 250 mg by mouth 4 times daily
during menses
35-C-It is a therapeutic option for any woman at low risk for sexually transmitted
diseases
501 MCQs \ REVIEW IN CLINICAL PHARMACY Dr. Hassan AL-Temimi 104
36-C-PCOS
37-A-A combination oral contraceptive containing ethinyl estradiol and drospirenone
38-A-A combination oral contraceptive containing ethinyl estradiol and drospirenone
39-D-Metformin
40-A-Hypoprothrombinemia
41-B-Ibuprofen 800 mg by mouth 3 times daily during menses
42-B-Levonorgestrel IUD
43-D-Topical heat
44-D-90
45-D-All of the above
46-B-Leuprolide
47-D-I, II, and III
48-C-Conservative surgery
49-A-I and II only
50-C-II and III only
51-D-Ethinyl estradiol/norgestimate contraceptive pill
52-C-Nafarelin
53-B-Pain relief at 2 months; incidence of weight gain, acne, and hirsutism
54-D-Increased levels of substance P
55-C-Conservative surgical therapy
56-A-Refer for assisted reproductive technology consultation.
57- B-Immunosuppressive activity
58-D-I, II, and III
59-D-Conjugated equine estrogens 0.3 mg/medroprogesterone 1.5 mg orally daily
60-D-Age 30, history of deep vein thrombosis and GnRH-a failure
61-A-Estrogen therapy
62-E-None of the above choices is correct
63-C-Increasing the daily estrogen dose
64-D-All of the above
65-D-Both a and b
66- C-Venlafaxine
67-A-FSH
68- None of the above choices is correct
69- E-Both choices b and c
70-A-Venous thromboembolism
71- B-Raloxifene
72- B-Hot flushes
73-D-Herbal products marketed for the relief of menopausal symptoms have been
shown to be effective and therefore should be recommended.
74- D-Low doses of estrogen without a progestin
75-C-Hormone therapy improves mood and well-being mainly in women with
vasomotor symptoms and sleep disturbance.
76-D-Renal toxicity
77-B-1,750 units
78- A-Decreased risk of viral contamination
79-A-Cyclophosphamide
501 MCQs \ REVIEW IN CLINICAL PHARMACY Dr. Hassan AL-Temimi 105
121-D-Esophageal pH monitoring
122-B-Assesses both acid and nonacid reflux
123-A-Bicarbonate
124-A-Rituximab and CHOP chemotherapy (R-CHOP)
125-C-About 30–60% of patients can be cured of their cancer
126-D-All of the above
127-B-Fatigue
128-A-Bone marrow aspiration and biopsy
129-E-Temsirolimus
130-B-Cyclophosphamide
131-B-1
132-D-All of the above
133-C-Lenalidomide 10 mg PO daily
134-A-Matched sibling donor allogeneic hematopoietic stem cell transplant
135-A-Azacitidine
136-B-A 35-year-old female with HLA DR15 expression who has required
transfusions for the past month.
137-A-Decrease serum ferritin, a blood test that indicates iron overload
138-C-A 72-year-old female requiring 1 red blood cell transfusion/month for the past 3
months with a serum erythropoietin level of 172 MIU/mL
139-A-Erythropoietin 40,000 units SQ + filgrastim 100 mcg SQ twice weekly
140-B-Rash and peripheral cytopenias
141-C-Peripheral cytopenias and hepatotoxicity
142-B-A male who uses 2 g of acetaminophen daily for his osteoarthritis
143-D-Present in one kidney rather than in both kidneys
144-B-Tumor suppressor gene
145-C-Mammalian target of rapamycin (mTOR)
146-C-Interferon
147-D-Interluekin-2
148-B-Temsirolimus
149-E-Everolimus
150-B- 5 mg daily
151-B- Benign intracranial hypertension (BIH)
152-C- Two - three months
153-E- Zoledronic acid
154-D- Trastuzumab
155-D- Danaparoid
156-B- Organ failure is a common finding in DIC
157-E- Reduced analgesia
158-E- Pinavarium
159-D- Short Synacthen test
160-C- DNA cross linkage
161-E- Tamoxifen
162-D- A packed cell transfusion should be given over 90 minutes
163-D- Phenytoin
164-C- Warfarin
501 MCQs \ REVIEW IN CLINICAL PHARMACY Dr. Hassan AL-Temimi 107
209-D-Insulin
210-A-Metformin
211-C-Start Ramipril, even if the person is not hypertensive
212-A-Do nothing, as you do not treat numb variant peripheral neuropathy if glycemic
control is excellent
213-E-Metformin 500 mg twice daily, simvastatin 20 mg daily, and aspirin 325 mg
daily
214-D-Dilated eye examination every 3 to 5 years
215-B-Inhibit iodine incorporation into tyrosine residues
216-C-Both propylthiouracil and methimazole are concentrated within the thyroid
gland
217-C-PTU use is contraindicated during the first trimester of pregnant
218-C-PTU may increase the efficacy of later treatment with radioactive iodine
219-C-Hypothyroidism generally occurs approximately 6 days after radioiodine
administration
220-B-T3 is not usually chosen for treatment of hypothyroidism because it has to be
given subcutaneously
221-D-Beta-blocker therapy
222-D-Its side effects can include hepatitis and agranulocytosis.
223-C-It produces stable serum levels of both T4 and T3.
224-B-rhTSH cannot be used to stimulate thyroglobulin production as part of the
diagnostic testing of patients with thyroid cancer.
225-D-Uterine contraction
226- B-Increased shoe size
227-C-Transsphenoidal surgery
228-C-Octreotide
229-Gastrointestinal adverse effects should subside within 10 to 14 days of therapy.
230-B-Physical height <2 standard deviations below the population mean
231-D-All of the above
232-B-GH-deficient short stature
233-D-All of the above
234-A-Menstrual irregularities
235-B-Antidepressants
236-C-Dopamine agonist therapy
237-C-Bromocriptine
238-B-Oral contraceptives
239- D-All of the above
240-B-Erectile dysfunction
241-D-Chronic cigarette smoking is thought to lead to erectile dysfunction.
242-B-Phosphodiesterase inhibitors
243-A-Acetylcholine
244-D-cGMP
245-A-Engage in foreplay prior to intercourse
246-E-Cyanopsia is caused by inhibition of phosphodiesterase type 6.
247-E-Both nitrates and phosphodiesterase inhibitors can produce hypotension.
248-D-Transdermal testosterone products bypass first-pass hepatic catabolism.
501 MCQs \ REVIEW IN CLINICAL PHARMACY Dr. Hassan AL-Temimi 109
294-E-Amiloride 5 mg daily
295-D-Hypovolemic hypernatremia
296-B-Furosemide
297-C-Adding metolazone
298-C-Alfacalcidol
299-D- Nicorandil
300-B- Digoxin
301-E-Ramipril
302- E- Factor VIII
303-E- None of these
304-A- ACE Inhibitor induced angioedema
305-B- Tacrolimus
306-D-Ciclosporin
307-C- Labetalol
308-D- Ramipril
309-D- Mesnaifosfamide induced hemorrhagic cystitis
310-A- Verapamil
311-D- Bendroflumethiazide
312-D- 5-HT1D receptor agonist
313-B- Methotrexate
314-C- Ciprofloxacin
315-D- Decreased heart rate
316-E- Amphetamine induced psychosis
317-C- Commence IV Thiamine
318-E- Fluoxetine
319-A- Haloperidol
320-A- Fetal alcohol syndrome
321-A- Naltrexone
322-E- Maintaining abstinence from alcohol
323-B- Serotonin
324-B-Oral atypical antipsychotics
325-C-Lorazepam
326-C- Valproate
327-B- Risperidone
328-A- Dalteparin
329-E- Initially rifampicin, isoniazid, ethambutol and pyrazinamide for 2 months then
isoniazid an rifampicin for further 4 months.
330-E- Initially rifampicin, isoniazid, ethambutol and pyrazinamide for 6 months
331-B- Tiotropium
332-C- Erythromycin
333-B- Pseudomonas aeruginosa
334-E- Streptomycin
335-A- Flucloxacillin
336-D- Prednisolone
337-B- IV magnesium sulphate
338-C-Trial of addition of long acting beta
501 MCQs \ REVIEW IN CLINICAL PHARMACY Dr. Hassan AL-Temimi 111
339-B- Amoxicillin
340-A- Rinse out mouth after use
341-A- Ethambutol
343-D-Has been shown to improve pain and functional status of OA patients
344-B-Help trigger degradation of articular cartilage by cleaving peptide bonds in
proteoglycans
345-B-Patient history, physical exam, and radiologic evaluation
346-E-All of the above
347-A-Block access of arachidonic acid to both COX-1 and COX-2 enzymes
348-E-a and b
349-B-Provide pain relief by the inhibition of prostaglandins
350-C-Is much safer to use for patients with compromised circulatory function
351-D-Are associated with hyperglycemia for patients without diabetes mellitus
352- A-Is made using recombinant technology
353-E-b and c
354-A-Nonselective NSAIDs used at analgesic doses, if the patient is not at high risk
for GI bleeding
355-B-If there is disability and interference with daily functioning
356-C-Is most effective when used on an as needed basis
357-C-Osteoarthritis
358-E-Decreased purine metabolism
359-A-First metatarsophalangeal joint
360-B-Alkaline urine
361-D-Women are affected three times more often than men.
362-D-Serum cholesterol
363-C-Colchicine
364-B-Constipation
365-D-Naproxen
366-B-Sodium bicarbonate
367-E-Underexcretion of uric acid
368-A-They should be given twice a day.
369-C-It could lead to chronic urate nephropathy if left untreated.
370-B-Corticosteroids
371-D-Cyclophosphamide
372-C-Hydroxychloroquine
373-B-Musculoskeletal
374-D-D-penicillamine
375-A-Prednisone
376-A- Filtration
377-B- Proximal tubule
378-D- decreases, increases
379-C- PTH
380- A- analytical
381- A- Serum creatinine
382- D- Urine sodium
383- C- Albumin:creatinine ratio
501 MCQs \ REVIEW IN CLINICAL PHARMACY Dr. Hassan AL-Temimi 112
References
1-Pharmacology, pretest self-assessment & review .marshal shlafar 14th edition 2013
2-Pass medicine 2009
3-Clinical pharmacology and therapeutics: questions for self-assessment. timothy gk
mant 2008. 3rd edition
4- Accp 2012 pharmacotherapy - mock exam
5- Harrison's internal medicine
principles of 15thedition. self-assessment and board review for use with the 15th
edition of Harrison's principles of internal medicine edited by Richard m. stone,
md.2001